1st Annual Live Medical Crossfire®: Expert Exchanges in Hematologic Malignancies
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 8.0 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie, Inc., AstraZeneca, Jazz Pharmaceuticals, Inc., Kite Pharma, Inc., Novartis Pharmaceuticals Corporation, and Takeda Oncology.

1st Annual Live Medical Crossfire®: Expert Exchanges in Hematologic Malignancies


July 15, 2017
InterContinental Hotel New York Times Square
300 West 44th Street
New York, NY 10036

Overview

Live Medical Crossfire®: Expert Exchanges in Hematologic Malignancies is a live, full-day version of the renowned Medical Crossfire format. This 1-day conference is designed to discuss some of the hottest clinical issues in the management of hematologic malignancies. The meeting is designed to facilitate the practical application of emerging data key to treating various forms of cancer, provide participants with the information they need to inform clinical decision making that allows for personalized approaches, and will ensure participants have the ability to safely apply novel strategies to real-world clinical case scenarios they routinely encounter in their practices.

For the Live Medical Crossfire®, we have assembled renowned experts in the management of leukemias, lymphomas, and myeloma to facilitate the Medical Crossfire. The program format for this meeting is unique. Each tumor’s section will begin with an evidence-based assessment of the evolving therapeutic space and transition quickly to the accompanying clinical questions that will be the focus of the expert crossfire session. Each section will conclude with a crossfire from the live audience at the meeting.

The exciting and innovative format of this meeting promises to provide clinicians with one of the most highly practical and engaging educational forums in medical education today.

Live Medical Crossfire®: Expert Exchanges in Hematologic Malignancies is a unique opportunity for practitioners who manage hematologic malignancies to learn from and interact with leading expert national faculty to build upon their clinical knowledge base, apply new data to practice, and ultimately improve their practices and patient outcomes.

Key topics on the agenda include:

  • Emerging strategies to assess and manage patients with high-risk acute myeloid leukemia
  • Methods to assess suboptimal response and what should inform your decision-making to switch therapies in chronic myeloid leukemia
  • Novel agents in multiple myeloma and how they should be optimally applied to care 
  • Emerging strategies in lymphomas, including the current status of CAR T cells in patients with these tumors
  • State-of-the-art methods to personalize and sequence chronic lymphocytic leukemia therapies

Target Audience:

This educational activity is directed toward medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer will be invited to participate.

Learning Objectives:

Upon completion of this activity, participants will be able to:

  • Describe major clinically unmet needs in the management of hematologic malignancies 
  • Explain clinical trial findings that inform decision-making concerning the management of hematologic malignancies
  • Detail proactive methods to mitigate and manage the impact of treatment-related toxicities associated with novel targeted and immunotherapeutic approaches
  • Place emerging data sets in the context of evolving treatment paradigms in the management of leukemias, lymphomas, and multiple myeloma


Program Co-Chairs

C. Ola Landgren, MD, PhD
Professor of Medicine and Chief of Myeloma Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Martin Tallman, MD
Professor of Medicine and Chief of Leukemia Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Anas Younes, MD
Professor of Medicine and Chief of Lymphoma Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
2627282930
Filter By